Genetic Engineering and Biotechnology News

Exploring the PI3K/AKT/mTOR Pathway

Novartis Oncology is investigating the PI3K/AKT/mTOR pathway to understand and treat advanced breast cancer.

ResourcesVideosBreast cancerCancersInternal medicineMedical oncologyMedicineMedicine, Diagnosis, and TherapeuticsSystemic conditionsNovartis
Also of Interest
Shionogi Grows Rare Disease Portfolio with $2B IntraBio Acquisition
FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
Advancing Brain Organoids from Research Models to Scalable Platforms
Microbiome Patterns Vary Among Individuals with Different Cancer Types and Onset Age
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
Cell Senescence 'Barcodes' Identified with Raman Microscopy and Gene Expression Data
Related Media
AACR 2026: A Video Update from San Diego
AI in Protein Design: Hype vs. Reality Explained by David Baker
AACR 2025: A Video Update from Chicago
AACR 2024: A Video Update from San Diego
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Breathing Oxygen Back into the Biological Conversation